A Yale-led randomized placebo-controlled trial in 2009 tested it specifically for fibromyalgia: both the treatment group and the placebo group improved, which suggests a strong placebo or volume-expansion effect on top of any direct nutrient benefit
#GlobalHealth #BiotechInnovation #ObesityCrisis China approves first home-grown GLP-1 weight loss drug, rivaling Ozempic Chinas approval of mazdutide, its first home-grown GLP-1/glucagon weight loss drug, marks a pivotal step in combating obesity
The ones below are genuinely rare, but they share a common trait: the faster you recognize them, the better the outcome
Meanwhile, Express Scripts launched ClearNetwork, which will use predictive acquisition cost, national average drug acquisition cost, or wholesale acquisition cost to project an individual drugs price
Sharma NM, Liu X, Llewellyn TL, Katsurada K, Patel KP
Neves JS, Borges-Canha M, Vasques-Nvoa F, Green JB, Leiter LA, Granger CB, et al